Record Information |
---|
Version | 2.0 |
---|
Created at | 2024-03-06 08:06:28 UTC |
---|
Updated at | 2024-09-03 04:19:43 UTC |
---|
NP-MRD ID | NP0332592 |
---|
Natural Product DOI | https://doi.org/10.57994/1852 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Compound 12a |
---|
Description | Compound 13a belongs to the class of organic compounds known as 7,9'-epoxylignans. These are lignans that contain the 7,9'-epoxylignan skeleton, which consists of a tetrahydrofuran that carries a phenyl group, a methyl group, and a benzyl group at the 2-, 3-, 4-position, respectively. Compound 12a was first documented in 2023 (PMID: 37722267). Based on a literature review a small amount of articles have been published on Compound 13a (PMID: 39311818) (PMID: 39047608) (PMID: 38797442) (PMID: 37379240). |
---|
Structure | [H][C@@]1(CO[C@@H](C2=CC(OC)=C(OC)C=C2)[C@]1([H])COC(C)=O)[C@H](OC(=O)[C@H](OC)C1=CC=CC=C1)C1=CC=C(OC)C(OC)=C1 InChI=1S/C33H38O10/c1-20(34)41-18-24-25(19-42-30(24)22-12-14-26(36-2)28(16-22)38-4)31(23-13-15-27(37-3)29(17-23)39-5)43-33(35)32(40-6)21-10-8-7-9-11-21/h7-17,24-25,30-32H,18-19H2,1-6H3/t24-,25+,30+,31-,32-/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C33H38O10 |
---|
Average Mass | 594.6570 Da |
---|
Monoisotopic Mass | 594.24650 Da |
---|
IUPAC Name | (S)-[(3R,4S,5R)-4-[(acetyloxy)methyl]-5-(3,4-dimethoxyphenyl)oxolan-3-yl](3,4-dimethoxyphenyl)methyl (2R)-2-methoxy-2-phenylacetate |
---|
Traditional Name | (S)-[(3R,4S,5R)-4-[(acetyloxy)methyl]-5-(3,4-dimethoxyphenyl)oxolan-3-yl](3,4-dimethoxyphenyl)methyl (2R)-2-methoxy-2-phenylacetate |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@@]1(CO[C@@H](C2=CC(OC)=C(OC)C=C2)[C@]1([H])COC(C)=O)[C@H](OC(=O)[C@H](OC)C1=CC=CC=C1)C1=CC=C(OC)C(OC)=C1 |
---|
InChI Identifier | InChI=1S/C33H38O10/c1-20(34)41-18-24-25(19-42-30(24)22-12-14-26(36-2)28(16-22)38-4)31(23-13-15-27(37-3)29(17-23)39-5)43-33(35)32(40-6)21-10-8-7-9-11-21/h7-17,24-25,30-32H,18-19H2,1-6H3/t24-,25+,30+,31-,32-/m1/s1 |
---|
InChI Key | GAAGPAPKKCIDKB-FQNMNJODSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
COSY NMR | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | Not Available | Keio University | Haruhisa Kikuchi | 2024-03-06 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | Not Available | Keio University | Haruhisa Kikuchi | 2024-03-06 | View Spectrum |
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | This compound belongs to the class of organic compounds known as 7,9'-epoxylignans. These are lignans that contain the 7,9'-epoxylignan skeleton, which consists of a tetrahydrofuran that carries a phenyl group, a methyl group, and a benzyl group at the 2-, 3-, 4-position, respectively. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lignans, neolignans and related compounds |
---|
Class | Furanoid lignans |
---|
Sub Class | Tetrahydrofuran lignans |
---|
Direct Parent | 7,9'-epoxylignans |
---|
Alternative Parents | |
---|
Substituents | - 7,9p-epoxylignan
- Fatty alcohol ester
- Benzyloxycarbonyl
- Benzylether
- Phenoxy compound
- Methoxybenzene
- Phenol ether
- Anisole
- Fatty acid ester
- Alkyl aryl ether
- Fatty acyl
- Benzenoid
- Dicarboxylic acid or derivatives
- Monocyclic benzene moiety
- Tetrahydrofuran
- Carboxylic acid ester
- Oxacycle
- Organoheterocyclic compound
- Ether
- Dialkyl ether
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Zhang R, Su K, Yang L, Duan H, Tang L, Tang M, Zhao M, Ye N, Cai X, Jiang X, Li N, Peng J, Zhang X, Tang L, Qiu Q, Chen L, Wu W, Hu J, Ma L, Ye H: Discovery of a Potent, Orally Active, and Long-Lasting P2X7 Receptor Antagonist as a Preclinical Candidate for Delaying the Progression of Chronic Kidney Disease. J Med Chem. 2024 Sep 23. doi: 10.1021/acs.jmedchem.4c01395. [PubMed:39311818 ]
- Liu E, Chen Y, Qin M, Yue K, Sun S, Jiang Y, Li X: Design, synthesis, and biological activity evaluation of novel HDAC3 selective inhibitors for combination with Venetoclax against acute myeloid leukemia. Eur J Med Chem. 2024 Oct 5;276:116663. doi: 10.1016/j.ejmech.2024.116663. Epub 2024 Jul 18. [PubMed:39047608 ]
- Perina M, Borzsei R, Henrietta Agoston, Hlogyik T, Poor M, Rigo R, Ozvegy-Laczka C, Batta G, Hetenyi C, Vojackova V, Jorda R, Mernyak E: Synthesis and estrogenic activity of BODIPY-labeled estradiol conjugates. Eur J Pharm Sci. 2024 Aug 1;199:106813. doi: 10.1016/j.ejps.2024.106813. Epub 2024 May 24. [PubMed:38797442 ]
- Namballa HK, Decker AM, Dorogan M, Gudipally A, Goclon J, Harding WW: Fluoroalkoxylated C-3 and C-9 (S)-12-bromostepholidine analogues with D1R antagonist activity. Bioorg Chem. 2023 Dec;141:106862. doi: 10.1016/j.bioorg.2023.106862. Epub 2023 Sep 12. [PubMed:37722267 ]
- Elkady H, El-Adl K, Sakr H, Abdelraheem AS, Eissa SI, El-Zahabi MA: Novel promising benzoxazole/benzothiazole-derived immunomodulatory agents: Design, synthesis, anticancer evaluation, and in silico ADMET analysis. Arch Pharm (Weinheim). 2023 Sep;356(9):e2300097. doi: 10.1002/ardp.202300097. Epub 2023 Jun 28. [PubMed:37379240 ]
|
---|